Jennifer K Burton1, Richard Papworth2, Caroline Haig2, Colin McCowan2, Ian Ford2, David J Stott3, Terence J Quinn4. 1. Alzheimer Scotland Dementia Research Centre and Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, Scotland, UK. 2. Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland, UK. 3. Academic Geriatric Medicine, Institute of Cardiovascular and Medical Sciences, Glasgow Royal Infirmary, University of Glasgow, Room 2.44, New Lister Building Campus, Glasgow, G4 0SF, Scotland, UK. 4. Academic Geriatric Medicine, Institute of Cardiovascular and Medical Sciences, Glasgow Royal Infirmary, University of Glasgow, Room 2.44, New Lister Building Campus, Glasgow, G4 0SF, Scotland, UK. terry.quinn@glasgow.ac.uk.
Abstract
BACKGROUND: Statins have been associated with later life, long-term care admission in observational studies. However, by preventing vascular events, statins may also prevent or delay admission. We wished to determine statin and long-term care admission associations in a randomised controlled trial context, and describe associations between long-term care admission and other clinical and demographic factors. METHODS: We used extended follow-up of two randomised trial populations, using national data to assign the long-term care admission outcome, and included individuals screened or recruited to two large randomised trials of pravastatin 40 mg daily-the West of Scotland Coronary Prevention Study (WOSCOPS) and the pravastatin in elderly individuals at risk of vascular disease (PROSPER) study. We described univariable and multivariable analyses of potential predictors of long-term care admission with corresponding survival curves of incident long-term care admission and analyses adjusted for competing risk. RESULTS: In total 11,015 (10%) of the trial participants were admitted to long-term care. There was no difference between participants in the statin or placebo arms of either trial in regard to admissions to long-term care. On multivariable analyses, independent associations with incident long-term care admission in the PROSPER trial were age (hazard ratio [HR] 1.06 per year, 95% confidence interval [CI] 1.03-1.09) and male sex (HR 0.72, 95% CI 0.53-0.99). In the WOSCOPS, age (HR 1.12 per year, 95% CI 1.10-1.13) and increasing social deprivation (HR 1.05, 95% CI 1.03-1.08) were associated with incident long-term care admission. CONCLUSION: We did not demonstrate an association between historical statin use and future long-term care admission. The strongest associations with incident long-term care admission were non-modifiable factors of age, sex and socioeconomic deprivation.
BACKGROUND: Statins have been associated with later life, long-term care admission in observational studies. However, by preventing vascular events, statins may also prevent or delay admission. We wished to determine statin and long-term care admission associations in a randomised controlled trial context, and describe associations between long-term care admission and other clinical and demographic factors. METHODS: We used extended follow-up of two randomised trial populations, using national data to assign the long-term care admission outcome, and included individuals screened or recruited to two large randomised trials of pravastatin 40 mg daily-the West of Scotland Coronary Prevention Study (WOSCOPS) and the pravastatin in elderly individuals at risk of vascular disease (PROSPER) study. We described univariable and multivariable analyses of potential predictors of long-term care admission with corresponding survival curves of incident long-term care admission and analyses adjusted for competing risk. RESULTS: In total 11,015 (10%) of the trial participants were admitted to long-term care. There was no difference between participants in the statin or placebo arms of either trial in regard to admissions to long-term care. On multivariable analyses, independent associations with incident long-term care admission in the PROSPER trial were age (hazard ratio [HR] 1.06 per year, 95% confidence interval [CI] 1.03-1.09) and male sex (HR 0.72, 95% CI 0.53-0.99). In the WOSCOPS, age (HR 1.12 per year, 95% CI 1.10-1.13) and increasing social deprivation (HR 1.05, 95% CI 1.03-1.08) were associated with incident long-term care admission. CONCLUSION: We did not demonstrate an association between historical statin use and future long-term care admission. The strongest associations with incident long-term care admission were non-modifiable factors of age, sex and socioeconomic deprivation.
Authors: M W Ribbe; G Ljunggren; K Steel; E Topinková; C Hawes; N Ikegami; J C Henrard; P V Jónnson Journal: Age Ageing Date: 1997-09 Impact factor: 10.668
Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245
Authors: Catriona Murphy; Kathleen Bennett; Tom Fahey; Emer Shelley; Ian Graham; Rose Anne Kenny Journal: BMJ Open Date: 2015-07-13 Impact factor: 2.692
Authors: Ian Ford; Gerard Jan Blauw; Michael B Murphy; James Shepherd; Stuart M Cobbe; Edward LEM Bollen; Brendan M Buckley; J Wouter Jukema; Michael Hyland; Allan Gaw; A Margot Lagaay; Ivan J Perry; Peter Macfarlane; John Norrie; A Edo Meinders; Brian J Sweeney; Chris J Packard; Rudi GJ Westendorp; Cillian Twomey; David J Stott Journal: Curr Control Trials Cardiovasc Med Date: 2002-05-20
Authors: Martin Wawruch; Gejza Wimmer; Jan Murin; Martina Paduchova; Tomas Tesar; Lubica Hlinkova; Peter Slavkovsky; Lubomira Fabryova; Emma Aarnio Journal: Drugs Aging Date: 2019-09 Impact factor: 3.923